RAPT Therapeutics Inc., a clinical-stage biopharmaceutical company specializing in inflammatory and immunological diseases, announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. The company will engage in a fireside chat on June 10, 2025, at 9:20 a.m. ET.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.